Log in to save to my catalogue

Elevated levels of CSF p‐tau212 in FTLD‐Tau

Elevated levels of CSF p‐tau212 in FTLD‐Tau

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716833

Elevated levels of CSF p‐tau212 in FTLD‐Tau

About this item

Full title

Elevated levels of CSF p‐tau212 in FTLD‐Tau

Publisher

Hoboken: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2024-12, Vol.20 (S2), p.n/a

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley and Sons Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background
Phosphorylated‐tau (p‐tau) biomarkers are typically specific for Alzheimer’s disease (AD) and are less elevated in the cerebrospinal fluid (CSF) of frontotemporal lobar degeneration (FTLD) type tau (FTLD‐tau). FTLD is a pathologically and clinically heterogenous neurodegenerative disorder, and we currently lack biomarkers to different...

Alternative Titles

Full title

Elevated levels of CSF p‐tau212 in FTLD‐Tau

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716833

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716833

Other Identifiers

ISSN

1552-5260

E-ISSN

1552-5279

DOI

10.1002/alz.090278

How to access this item